Phenothiazine

Phenothiazine

SCHEMBL19350276

CN(C)Cl.c1ccc2c(c1)Nc1ccccc1S2

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 10/20 0.74
MAPT P10636 7/20 0.74
GAA P10253 6/20 0.74
MEN1 O00255 3/20 0.74
KMT2A Q03164 3/20 0.74
SNCA P37840 3/20 0.74
ALOX15 P16050 3/20 0.74
BCHE P06276 2/20 0.74
ACHE P22303 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
CYP1A2 P05177 2/20 0.74
ALOX12 P18054 2/20 0.74
POLB P06746 1/20 0.74
CYP3A4 P08684 1/20 0.74
ADORA3 P0DMS8 1/20 0.74
MAOA P21397 1/20 0.74
CNR1 P21554 1/20 0.74
PTGS1 P23219 1/20 0.74
SLC6A2 P23975 1/20 0.74
HTR2C P28335 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenothiazine SCHEMBL27531802 0.91 NOX1 (0.81) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL29349533 0.86 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL29352248 0.86 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL9114 0.86 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL6315328 0.86 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL2504207 0.86 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL30979183 0.84 NOX1 (0.85) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL27563630 0.84 NOX1 (0.85) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL9347283 0.84 NOX1 (0.85) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL23295987 0.84 NOX1 (0.94) NOX1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10160735-B2 Process for the purification of diaminophenothiazinium compounds EUPHARMA PTY LTD (AU) 2018-12-25 US disclosed
EP-3033331-B1 PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS EUPHARMA PTY LTD (AU) 2018-02-21 EP disclosed
US-20170267652-A1 PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS EUPHARMA PTY LTD (AU) 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267652-A1 PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS QDPR, DDC, DDT NOX1 2390/4885MAPT 173/4885GAA 1616/4885
US-10160735-B2 Process for the purification of diaminophenothiazinium compounds QDPR, DDC, DDT NOX1 2608/4885MAPT 180/4885GAA 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.